In the wake of another profit warning from Australian insurer QBE, investors and analysts have been left to the count the cost of the firm's ambitious US M&A strategy, which is now acting as a profit-sapping deadweight on the...
In the wake of another profit warning from Australian insurer QBE, investors and analysts have been left to the count the cost of the firm's ambitious US M&A strategy, which is now acting as a profit-sapping deadweight on the...